Comparing Wound Area Reduction of Non-healing DFUs Using MolecuLight i:X Versus Standard of Care (WAR)
A 12-week, Prospective, Parallel Arm, Randomized Controlled Trial (RCT) Comparing Wound Area Reduction of Non-healing Diabetic Foot Ulcers With MolecuLight i:X Used in Standard of Care Compared to Standard of Care Alone
Sponsor: MolecuLight Inc.
A observational or N/A phase clinical study on Non Healing Diabetic Foot Ulcer, this trial is ongoing. The trial is conducted by MolecuLight Inc. and has accumulated 8 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Oct 2023 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Oct 2021 — Oct 2023 [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting
▶ Show 3 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Apr 2020 — Dec 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2020 — Apr 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- MolecuLight Inc.
For direct contact, visit the study record on ClinicalTrials.gov .